Immune Activation Key to Dual-Target CAR T Therapy Success in Glioblastoma
Researchers at the University of Pennsylvania's Perelman School of Medicine have been testing a new treatment for recurrent glioblastoma. The therapy involves injecting dual-target CAR T-cells…